PL3489231T3 - Pochodne piperazyny - Google Patents
Pochodne piperazynyInfo
- Publication number
- PL3489231T3 PL3489231T3 PL17830975T PL17830975T PL3489231T3 PL 3489231 T3 PL3489231 T3 PL 3489231T3 PL 17830975 T PL17830975 T PL 17830975T PL 17830975 T PL17830975 T PL 17830975T PL 3489231 T3 PL3489231 T3 PL 3489231T3
- Authority
- PL
- Poland
- Prior art keywords
- piperazine derivative
- piperazine
- derivative
- Prior art date
Links
- 150000004885 piperazines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016141542 | 2016-07-19 | ||
| EP17830975.3A EP3489231B1 (en) | 2016-07-19 | 2017-07-18 | Piperazine derivative |
| PCT/JP2017/025842 WO2018016458A1 (ja) | 2016-07-19 | 2017-07-18 | ピペラジン誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3489231T3 true PL3489231T3 (pl) | 2021-10-25 |
Family
ID=60992481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17830975T PL3489231T3 (pl) | 2016-07-19 | 2017-07-18 | Pochodne piperazyny |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10710988B2 (pl) |
| EP (1) | EP3489231B1 (pl) |
| JP (1) | JP6908041B2 (pl) |
| CN (1) | CN109563074B (pl) |
| AR (1) | AR109086A1 (pl) |
| ES (1) | ES2880174T3 (pl) |
| PL (1) | PL3489231T3 (pl) |
| PT (1) | PT3489231T (pl) |
| TW (1) | TW201811769A (pl) |
| WO (1) | WO2018016458A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018119142A1 (en) | 2016-12-21 | 2018-06-28 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| CN113929598A (zh) * | 2021-11-24 | 2022-01-14 | 上海吉奉生物科技有限公司 | 一种(s)-2-叔丁氧羰基氨基-3-(4,4-二氟环己基)丙酸的合成方法 |
| CN114478346A (zh) * | 2021-12-31 | 2022-05-13 | 和鼎(南京)医药技术有限公司 | 一种制备乌帕替尼中间体的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7115607B2 (en) | 2001-07-25 | 2006-10-03 | Amgen Inc. | Substituted piperazinyl amides and methods of use |
| WO2003061660A1 (en) * | 2002-01-23 | 2003-07-31 | Eli Lilly And Company | Melanocortin receptor agonists |
| WO2004078717A1 (en) | 2003-03-03 | 2004-09-16 | Merck & Co., Inc. | Acylated piperazine derivatives as melanocortin-4 receptor agonists |
| US20050192286A1 (en) | 2003-10-22 | 2005-09-01 | Neurocrine Biosciences, Inc. | Ligands of melanocortin receptors and compositions and methods related thereto |
| EP1773338B1 (en) | 2004-07-19 | 2010-01-06 | Merck & Co., Inc. | Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| JP2009503048A (ja) | 2005-08-01 | 2009-01-29 | ファイザー・リミテッド | 尿路機能障害を治療するためのmc4r作動薬 |
| PL3333165T3 (pl) * | 2015-08-04 | 2019-12-31 | Astellas Pharma Inc. | Pochodne piperazyny |
-
2017
- 2017-07-18 AR ARP170101999A patent/AR109086A1/es unknown
- 2017-07-18 ES ES17830975T patent/ES2880174T3/es active Active
- 2017-07-18 JP JP2018528537A patent/JP6908041B2/ja not_active Expired - Fee Related
- 2017-07-18 EP EP17830975.3A patent/EP3489231B1/en active Active
- 2017-07-18 CN CN201780044430.5A patent/CN109563074B/zh not_active Expired - Fee Related
- 2017-07-18 WO PCT/JP2017/025842 patent/WO2018016458A1/ja not_active Ceased
- 2017-07-18 US US16/314,730 patent/US10710988B2/en not_active Expired - Fee Related
- 2017-07-18 PL PL17830975T patent/PL3489231T3/pl unknown
- 2017-07-18 TW TW106123979A patent/TW201811769A/zh unknown
- 2017-07-18 PT PT178309753T patent/PT3489231T/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW201811769A (zh) | 2018-04-01 |
| CN109563074B (zh) | 2021-09-28 |
| JPWO2018016458A1 (ja) | 2019-05-09 |
| JP6908041B2 (ja) | 2021-07-21 |
| US20190202815A1 (en) | 2019-07-04 |
| US10710988B2 (en) | 2020-07-14 |
| PT3489231T (pt) | 2021-07-14 |
| EP3489231A1 (en) | 2019-05-29 |
| ES2880174T3 (es) | 2021-11-23 |
| WO2018016458A1 (ja) | 2018-01-25 |
| CN109563074A (zh) | 2019-04-02 |
| EP3489231B1 (en) | 2021-06-09 |
| EP3489231A4 (en) | 2020-03-04 |
| AR109086A1 (es) | 2018-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3478217T3 (en) | Historisk scanningsreference for intraorale scanninger | |
| IL253381A0 (en) | History of h9-pyrrolo-dipyridine | |
| ZA201704602B (en) | Dihydroindolizinone derivative | |
| SG11201609205WA (en) | Heterocyclyl-butanamide derivatives | |
| PL3418273T3 (pl) | Pochodne flawaglin | |
| HUE050450T2 (hu) | Fluoralkil-fluorén-származékok | |
| IL248773A0 (en) | History of naphthyridinedione | |
| IL251005B (en) | Pyrido-oxazinone derivatives | |
| IL257264A (en) | Consequence of piperazine | |
| AP2016009530A0 (en) | Cycloalkyl-linked diheterocycle derivatives | |
| IL248772A0 (en) | A consequence of cyclohexyl pyridine | |
| PT3489231T (pt) | Derivado de piperazina | |
| PL3119744T3 (pl) | Pochodne 2-cyjano-3-cyklopropylo-3-hydroksy-N-arylo-tioakryloamidu | |
| ZA201604927B (en) | Aminopyrazolone derivative | |
| SG11201609359WA (en) | Pyrazine derivative | |
| ZA201802194B (en) | Aminoazole derivative | |
| GB2548396B (en) | Bed | |
| GB2531157B (en) | Cut-out assembly | |
| PT3319956T (pt) | Derivados de oxopiridina substituída |